China's Sinovac Delays Covid-19 Vaccine Trial Results

Updated Dec. 23, 2020 5:02 pm ET
SÃO PAULO—Chinese firm Sinovac Biotech Ltd. has delayed the announcement of results from late-stage trials of its Covid-19 vaccine to January as it consolidates data from Brazil with test results from Indonesia and Turkey.
Brazil, which is the first country to complete Phase 3 trials of CoronaVac, had been expected to announce the vaccine’s efficacy rate on Wednesday. However, Brazil’s Butantan Institute, the research center backed by São Paulo’s state government that has been testing CoronaVac, said Sinovac asked for 15 more days to analyze the data together with results from other trials of the vaccine, which is also being tested in Indonesia and Turkey.

Related Keywords

China ,Indonesia ,Turkey ,Campinas ,Sãpaulo ,Brazil ,Chinese ,Brazilian ,Dimas Covas ,Luiz Carlos Dias ,Brazil Butantan Institute ,Sinovac Biotech Ltd ,University Of Campinas ,Sinovac Biotech ,Butantan Institute ,சீனா ,இந்தோனேசியா ,வான்கோழி ,காம்பினாக்கள் ,பிரேசில் ,சீன ,பிரேசிலியன் ,டைமாஸ் கோவாஸ் ,லூயிஸ் கார்லோஸ் டயஸ் ,பிரேசில் புத்தாண்தான் நிறுவனம் ,பல்கலைக்கழகம் ஆஃப் காம்பினாக்கள் ,புத்தாண்தான் நிறுவனம் ,